Page 3,274«..1020..3,2733,2743,2753,276..3,2803,290..»

Aesthetic Medicine – AAAMED.ORG

Posted: Published on November 3rd, 2014

Aesthetic Medicine comprises all medical proceduresthat are aimed at improving the physical appearance and satisfaction of the patient, using non-invasive to minimally invasive cosmetic procedures. The Aesthetic Medicine specialty is not confined to dermatologists and plastic surgeons as doctors of all specialties seek to offer services to address their patients aesthetic needs and desires. All Aesthetic Medicine procedures are performed under loco-regional anesthesia. The exciting field of Aesthetic Medicine is a new trend in modern medicine. Patients not only want to be in good health, they also want to enjoy life to the fullest, be fit and minimize the effects of normal aging. Indeed, patients are now requesting quick, non-invasive procedures with minor downtime and very little risk. As a general rule, the needle is increasingly replacing the scalpel. This recent trend explains the current success of Aesthetic Medicine around the globe. These aesthetic procedures consist of: The real benefit of practicing Aesthetic Medicine is the type of care that practitioners are offering to their patients. These procedures are elective and are performed on patients who do not suffer from illness. They are usually happy and in excellent health. They simply want a minimally invasive preventative procedure to help manage … Continue reading →

Posted in Aesthetic Medicine | Comments Off on Aesthetic Medicine – AAAMED.ORG

PURTIER LIVE STEM CELL THERAPY – Video

Posted: Published on November 3rd, 2014

PURTIER LIVE STEM CELL THERAPY PURTIER INTRODUCTION IN CHINESE Please contact Pearly @ +65 9338 9541 / +65 9189 7351 for more details. By: Purtier30 … Continue reading →

Comments Off on PURTIER LIVE STEM CELL THERAPY – Video

Netherlands Kiadis gets EMA orphan drug status for ATIR to treat acute myeloid leukemia

Posted: Published on November 3rd, 2014

PBR Staff Writer Published 03 November 2014 Dutch biopharmaceutical firm Kiadis Pharma has received orphan drug designation (ODD) from the European Medicines Agency (EMA) for its T-cell immunotherapy based medicinal product ATIR to treat acute myeloid leukemia (AML). Previously, ATIR was also granted ODD by both the EMA and the US Food and Drug Administration (FDA) for the prevention of acute graft versus host disease (GvHD) following an allogeneic bone marrow transplantation. ATIR allows stem cell transplantations using partially mismatched family members as donors for patients suffering from blood cancer who do not have a standard of care matching stem cell donor available. For many patients hematopoietic stem cell transplantation (HSCT) is the only potentially curative option but a matching donor is available for only half of the patients in need. Kiadis Pharma chief executive officer Manfred Ruediger said: "This second Orphan Drug Designation for our lead product ATIR in the European Union represents another very important milestone in the development of our product. "This, coupled with the previously granted ODDS for ATIR by the FDA and EMA, further highlights our product's importance as a novel approach which may help provide a potentially life-saving transplant from a family member to … Continue reading →

Posted in FDA Stem Cell Trials | Comments Off on Netherlands Kiadis gets EMA orphan drug status for ATIR to treat acute myeloid leukemia

BioTimes Subsidiary Cell Cure Neurosciences Receives FDA Authorization to Initiate Phase I/IIa Trial of Embryonic …

Posted: Published on November 3rd, 2014

OpRegen consists of animal product-free retinal pigment epithelial (RPE) cells with high purity and potency that were derived from human embryonic stem cells (hESCs). Cell Cure will conduct the trial in Israel where OpRegen will be transplanted as a single dose into the subretinal space of the eye to test the safety and efficacy of the product. Patient enrollment is expected to begin in 2014 following approval of the trial by the Israel Ministry of Health. About the OpRegenClinical Trial Cell Cures Phase I/IIa clinical trial is a dose escalation safety and preliminary efficacy study of hESC-derived Retinal Pigment Epithelial (RPE) cells transplanted subretinally in patients with advanced dry-form AMD called geographic atrophy. The open-label, single center, nonrandomized trial will evaluate three different dose regimens of 50,000 to 500,000 cells. A total of 15 patients will be enrolled. The patients will be 55 years of age and older, with non-neovascular (dry-AMD) who have funduscopic findings of GA in the macula with absence of additional concomitant ocular disorders. The eye most affected by the disease will be treated with the contralateral eye being the control. Following transplantation, the patients will be followed for 12 months at specified intervals, to evaluate the … Continue reading →

Posted in Stem Cell Human Trials | Comments Off on BioTimes Subsidiary Cell Cure Neurosciences Receives FDA Authorization to Initiate Phase I/IIa Trial of Embryonic …

Def Leppard – Chumash Casino Resort 10/30/14 #3 – Video

Posted: Published on November 3rd, 2014

Def Leppard - Chumash Casino Resort 10/30/14 #3 Joe Elliott intros Steve Brown of Trixter, filling in for Vivian Campbell who was getting stem cell treatment at the time of this show.'Armageddon It' and'Make Love Like A Man' - Samala Showroom... By: marshallofrock … Continue reading →

Comments Off on Def Leppard – Chumash Casino Resort 10/30/14 #3 – Video

Pioneers of transplantation John Gurdon – Video

Posted: Published on November 3rd, 2014

Pioneers of transplantation John Gurdon Interview with Sir John Gurdon, developmental biologist and forefather of stem cell medicine. The footage, produced by Figment Productions, formed part of an exhibition organised by the MRC... By: Medical Research Council … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Pioneers of transplantation John Gurdon – Video

Perelman School of Medicine at the University of Pennsylvania

Posted: Published on November 3rd, 2014

Penn Medicine Signs Contract to Provide EMS Services to Haverford Township 1 Nov 2014Officials from Penn Medicine and Haverford Township today put into action a contract making Penn Medicine the sole provider of ambulance and emergency medical services (EMS) for the township. Read more 30 Oct 2014A study led by investigators from Massachusetts General Hospital and the Perelman School of Medicine at the University of Pennsylvania has identified a potential target for therapies to treat cocaine addiction. Read more 27 Oct 2014A new effort mapping 24-hr patterns of expression for thousands of genes in 12 different mouse organs five years in the making provides important clues about how the role of timing may influence the way drugs work in the body. Read more 27 Oct 2014An all-female panel of luminaries in fields including epigenetics and stem cell biology will come together at a Penn symposium entitled Celebrating Women in Science. The Department of Cell and Developmental Biology at the Perelman School of Medicine, University of Pennsylvania, has organized the... Read more 22 Oct 2014A Penn Medicine-developed drug has received orphan status from the Food and Drug Administration (FDA) this month for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare, … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Perelman School of Medicine at the University of Pennsylvania

Cell Therapy Blog: Cell Therapy Conferences 2014

Posted: Published on November 3rd, 2014

JANUARY 2014 State of the Industry Briefing at EBD's Biotech Showcase Jan 13. San Francisco, CA EBD's Biotech Showcase: Regenerative Medicine Industry Track Jan 13-15. San Francisco, CA ECI's Conference on Scale-Up and Manufacturing of Cell-Based Therapies Jan 6-9. San Diego, CA International Conference on Cell Therapy for Cardiovascular Disease Jan 22-24. New York, NY Phacilitate's Cell and Gene Therapy Forum Jan 27-29. Washington, DC FEBRUARY 2014 RRY's New York Stem Cell Summit Feb 18. New York, NY STEMSO's International Stem Cell Society Conference Feb 19-22. Freeport, Grand Bahama BMT Tandem Meetings Feb 26-Mar.Grapevine (Dallas), TX MARCH 2014 Danish Stem Cell Symposium Mar 7-8. Hillerd, Denmark ISBioTech Spring Mtg - Cellular Therapies Track Mar 10-12. Washington, DC AAT's Advanced Therapies Summit Mar 12-13. Turin, Italy ISSCR/SBE International Conference on Stem Cell Engineering Mar 16-19. Coronado, CA Congress on Stem Cell and Cell Therapies Mar 2023. Koceli, Turkey FDA and the Changing Paradigm for HCT/P Regulation Mar 24-26. Bethesda, MD BIRAXs' UK-Israel Regenerative Medicine Conference Mar 25-26. Haifa, Israel ARM's RegenMed Investor Day Mar 26. New York, NY. Regenerative Medicine Workshop at Hilton Head Mar 26-29 . Hilton Head, SC Cancer Immunotherapy: A Long-Awaited Reality Mar 27. NYC, NY. FDA Workshop: … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Cell Therapy Blog: Cell Therapy Conferences 2014

Public hospitals urged to hire more genetics counselors to treat rare diseases

Posted: Published on November 3rd, 2014

MANILA, Philippines An academician wants the countrys hospitals to employ genetics counselors for the effective treatment and care of patients with rare diseases. Carmencita Padilla, a member of the National Academy of Science and Technology (NAST) and a professor at the University of the Philippines (UP) Manila College of Medicine, said the move would address both the gaps in medical services given to such patients and the small number of geneticists in the Philippines. According to Padilla, there are only nine geneticists in the country, seven of whom are in Luzon and one each in the Visayas and Mindanao. Padilla, who spoke in a NAST forum in Manila last week, proposed that genetics counselors be included in the plantilla of secondary and tertiary hospitals nationwide to increase the number of geneticists in the country. A geneticist is a biologist specializing in the science of genes, heredity, and variation of organisms, managing and diagnosing patients with hereditary conditions or congenital deformities. We dont have enough geneticists and we dont need a geneticist in every hospital. At least, a genetics counselor can take care of counseling the patient and his family. The counselor is not limited to genetic conditions alone, Padilla said. … Continue reading →

Posted in Genetics | Comments Off on Public hospitals urged to hire more genetics counselors to treat rare diseases

Bomba DNA Advanced warface – Video

Posted: Published on November 3rd, 2014

Bomba DNA Advanced warface By: Dexter2468 … Continue reading →

Posted in DNA | Comments Off on Bomba DNA Advanced warface – Video

Page 3,274«..1020..3,2733,2743,2753,276..3,2803,290..»